patients, and was of "warm", "cold," and "mixed" types in seven, four, and four cases, respectively: it is important to recognise its presence in view of the good response to treatment. The increased incidence of erythrocyte autoantibodies in myelodysplastic syndromes is thought to be one manifestation of disturbed immune homeostasis.
SUMmARY Immunohaematological investigations were carried out in 46 patients with erythrocyte autoantibodies associated with myelodysplastic syndromes. Eight patients had refractory anaemia, 17 refractory anaemia with ring sideroblasts, 1 1 refractory anaemia with excess ofblasts, four chronic myelomonocytic leukaemia, five refractory anaemia with excess of blasts in transformation and one could not be classified. Standard agglutination direct antiglobulin tests showed that the red cells were most often coated with IgG and C3d, though increased amounts of IgM or IgA were also found in 15 of 35 cases (43%) when the more sensitive enzyme linked method was used. The IgG antibodies were predominantly of IgGl subclass. Clinically important autoimmune haemolysis occurred in 15 patients, and was of "warm", "cold," and "mixed" types in seven, four, and four cases, respectively: it is important to recognise its presence in view of the good response to treatment. The increased incidence of erythrocyte autoantibodies in myelodysplastic syndromes is thought to be one manifestation of disturbed immune homeostasis.
The myelodysplastic syndromes are a group of acquired disorders which usually occur in middle or later life and result from clonal abnormalities of haemopoietic stem cells.' 2 Autoantibodies to leucocytes and platelets were found in nine patients out of the 11 tested, while alloantibodies were detected in 13 subjects but not in four.
The overall incidence of new cases of myelodysplastic syndromes was 2-4 per 100 000 of the population per year; it increased noticeably with age, the figure being 11 1 for those over 60 years.
Discussion
Forty six patients with the recently recognised association of erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes were seen over 66 months. This association was seen in about 7% of patients with primary myelodysplasia and accounted for 2-6% of cases with erythrocyte autoantibodies referred during this time. The age range, with 87% being over 60, was similar to that of other studies.2 1'1-1
Autoantibodies were found in all types ofmyelodysplasia (table) Red cell alloantibodies were found in 26 patients (57%); this was not surprising in view of the history of multiple transfusions in all but four, and pregnancies in at least 15 of the 26 women. Anti-E and anti-K occurred most frequently, either alone or in combination with other alloantibodies (table). A similar pattern has been reported in other studies ofpatients with erythrocyte autoantibodies, though concomitant alloantibodies were less common.92324 Most of the patients had been transfused elsewhere, and had our policy of giving Kell negative blood of matched Rh phenotype been followed,9 alloimmunisation would have been less common.
Leucocyte and platelet antibody investigations were carried out in a few instances. The high incidence of both auto-and allo-antibodies was not unexpected in view of the probable disturbed immune homeostasis and the histories of pregnancies and multiple transfusions. These investigations were made either because of cytopenia or, more commonly, following a febrile transfusion reaction.
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